Addressing the Challenges of Translating LRRK2 Biology into Disease‐Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative
Movement Disorders, EarlyView.
Reader summaries
No reader summary yet. Contribute one with Claude — it takes a minute.